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Liakakos et al. [1] concluded from a retrospective series of
1,057 selected patients studied by Miyajima et al. [2] that
laparoscopic surgery for rectal cancer is safe. Although
cohort studies have shown safety, the most important out-
comes such as disease-free survival and the recurrence rate
need to be demonstrated in prospective randomized con-
trolled trials before laparoscopic surgery is accepted as the
standard approach.
Laparoscopic resection of colonic cancer is proved to be
safe, with no difference in long-term oncologic outcome
compared with open surgery [3–5]. However, long-term
outcome data after laparoscopic surgery for rectal cancer
still are not available.
Only 5 years ago, the first study investigating the quality
of the mesorectal dissection with 25 patients was published
[6]. The first randomization was done in the conventional
versus laparoscopically-assisted surgery in Colorectal
Cancer (CLASICC) trial with 253 patients treated with
laparoscopic surgery. The conversion rate at the beginning
of the trial was 34%, which decreased to 16% during the
sixth year of the study [5]. This high conversion rate in a
relatively small study group was due the experience curve
effect.
Miyajima et al. [2] concluded that laparoscopy is fea-
sible and safe for selected patients with rectal cancer, with
favorable short- and mid-term outcomes after a mean fol-
low-up period of 30 months. This retrospective study, not
intended to be a comparison between open and laparo-
scopic surgery, was reported without long-term outcome
data. Therefore, as stated by Liakakos et al. [1], more data
are needed from randomized controlled trials, if feasible, to
support the hypothesis of better oncologic outcomes for
closed rather than open surgery for rectal cancer.
Currently, several multicenter randomized controlled
trials comparing laparoscopic and open surgery for rectal
cancer are registered (Clinicaltrials.gov) and recruiting
patients, including the laparoscopic-assisted resection or
open resection in treating patients with Stage IIA, Stage
IIIA, or Stage IIIB rectal cancer (NCT00726622) trial by
the American College of Surgeons (estimated primary
completion date, August 2010) and the Phase II trial to
evaluate laparoscopic surgery for Stage 0/1 rectal carci-
noma (Lap RC), NCT00635466 (estimated study comple-
tion date, 2016).
In addition, the comparing laparoscopic and open sur-
gery for rectal cancer (COLOR II) trial (NCT00297791)
will fulfil the profound need for a well-designed and per-
formed randomized trial. Recently, this COLOR II trial
finished randomization of 1,100 patients. The short-term
results will be presented by the colorectal cancer laparo-
scopic or open resection study group on a short notice.
The primary end point of the COLOR II trial is the
locoregional recurrence rate 3 years postoperatively. Until
these data become available, we believe that open total
mesorectal excision must be regarded as the gold standard
treatment for rectal cancer.
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